 |  |
| ||||
Volume 49(569); March 1973 Introduction PMCID: PMC2495393 Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation PMCID: PMC2495385 Inactivated vaccines. 2. Laboratory indices of protection PMCID: PMC2495389 Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A PMCID: PMC2495381 Studies on influenza vaccine in industry PMCID: PMC2495387 The protective effect of intranasal immunization with inactivated influenza virus vaccine PMCID: PMC2495391 The potential role of immunological adjuvants in influenza vaccines PMCID: PMC2495378 A new subunit influenza vaccine: acceptability compared with standard vaccines and antigenicity in increasing dosage PMCID: PMC2495388 Fractionation of the influenza virus with the object of producing subunit vaccine PMCID: PMC2495384 Use of recombination in the production of influenza vaccine strains PMCID: PMC2495380 Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection PMCID: PMC2495394 Features of a successful therapeutic fast of 382 days' duration PMCID: PMC2495396 Tumours of the sigmoid colon following ureterosigmoidostomy PMCID: PMC2495395 A neonatal complication of maternal leukaemia treated with 6-mercaptopurine PMCID: PMC2495383 The auriculo-temporal syndrome. PMCID: PMC2495392 Journal Matter Original table of contents page Administrative content — journal masthead, notices, indexes, etc. Advertisements | ||
